On February 22nd and 23rd, we celebrated the start of the MIRACUM programme with a Kick-Off Symposium in Erlangen. With around 250 national and international guests, we succeeded to introduce the scope and spectrum of our consortium. Specifically, we demonstrated the structure of the MIRACUM Data Integration Centres, and we presented our three Use Cases to the broad audience: Use Case 1 focuses on “Study registries and patient recruitment”, Use Case 2 deals with “Prediction models for Asthma/COPD and brain tumours”, and Use Case 3 covers “Precision medicine with exemplary molecular tumour boards”. Of course, also the strategy for “Strengthening Medical Informatics” – e.g. our new master programme – was unfolded.
In addition, Sebastian Semler (head of the TMF) presented the structures of the National Steering Committee (NSC) of the Medical Informatics Initiative, and the NSC working groups “Interoperability”, “Data Sharing” and “Consent” were introduced, that represent important activities of standardization and dissemination and favourably complement the MIRACUM agenda. On top, we had the pleasure to have the members of our international scientific advisory board presenting on their research focuses including international data sharing, interoperability and big data in precision medicine.
The MIRACUM party night on February 22nd provided the perfect chance for networking and getting acquainted within the working groups of our project – with the GMDS Allstars being the icing on the cake.
Please find the presentations of the MIRACUM Kick-Off Symposium 2018 here.
Participating members of the MIRACUM International Scientific Advisory Board:
- Richard Frackowiak – Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
- Arie Hasman – Academic Medical Center of the University of Amsterdam, the Netherlands
- Kai U. Heitmann – HL7 Deutschland / Heitmann Consulting and Services / Gefyra GmbH, Köln
- George Hripcsak – Biomedical Informatics, Columbia University, New York City, USA
- Lisa McShane – Division of Cancer Treatment & Diagnosis NIH, Bethesda, USA
- Stefan Schulz – Institute of Medical Informatics, Statistics and Documentation, Medical University Graz, Austria
- Ahmet Zehir (on behalf of Charles Sawyers) – Clinical Bioinformatics, Memorial Sloan Kettering Cancer Center, New York City, USA